Henan Lingrui Pharmaceutical Co.,Ltd.’s Net Profit Rose 28.4% in 2022

Henan Lingrui Pharmaceutical Co.,Ltd. (河南羚锐制药股份有限公司) (600285.SH) reported a net profit of 465.3 million yuan in 2022, up 28.4% year-on-year.

Meanwhile, the company posted 3 billion yuan in revenue, up 11.4% year-on-year.

At the end of the reporting period, it had 4.3 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 41.1%.